Egg White (Gal d 4) IgE

If you or your child has had a reaction to eggs, the natural next question is what specifically the immune system is reacting to. Egg white is a mix of different proteins, and a blood test for IgE against Gal d 4 (lysozyme) measures sensitization to one of the lower-abundance fractions of that mix. It is part of a family of tests called component-resolved diagnostics, which break egg allergy down into its molecular pieces.

Of the four main egg white components, Gal d 4 (lysozyme) is the least useful for diagnosing or predicting egg reactions, although emerging data suggest it may be more immunogenic than historically appreciated. It can confirm that your immune system recognizes lysozyme, but on its own it tells you less than testing for whole egg white IgE or for Gal d 1 (ovomucoid). It is best understood as a supporting piece of evidence, not the main signal.

What Gal d 4 Actually Measures

Egg white contains four main allergenic components: ovomucoid (Gal d 1) makes up about 11 percent, ovalbumin (Gal d 2) about 54 percent, conalbumin/ovotransferrin (Gal d 3) about 12 percent, and lysozyme (Gal d 4) about 3.5 percent. Lysozyme is a small enzyme that naturally fights bacteria. This test measures IgE, the antibody class your body makes when it has tagged a food protein as something to react to.

When B cells in your immune system have learned to recognize lysozyme as a threat, they produce IgE that binds to mast cells and basophils, the cells that release histamine and other chemicals during an allergic reaction. A higher Gal d 4 IgE level means more of these specific antibodies are circulating in your blood, indicating sensitization to that particular protein.

Where Gal d 4 Fits in Egg Allergy

Egg allergy testing is built around understanding two scenarios: reacting to raw or lightly cooked egg, and reacting to baked or heated egg. Different proteins handle heat differently, which is why component testing matters. Gal d 1 (ovomucoid) is heat stable, so people sensitized to it often react even to thoroughly baked egg. Gal d 4 falls into the group of components that, on their own, carry weaker predictive value.

In a Finnish study of children undergoing supervised egg challenges, the diagnostic accuracy of each test was compared using a standard measure called AUC (where 1.0 is a perfect test and 0.5 is no better than chance). Gal d 1 was the strongest predictor of reactivity to heated egg (AUC 0.94), followed by whole egg white IgE (AUC 0.86), while Gal d 4 was the weakest of the four egg white components (AUC 0.77). In plain terms, Gal d 4 is a noticeably weaker predictor of who will actually react to heated egg than the other options.

Diagnostic Performance Across Studies

What this means for you: a Gal d 4 result is one data point in a broader picture. If you are trying to confirm or rule out an egg allergy, whole egg white IgE and Gal d 1 carry more weight. Gal d 4 is most useful when looked at alongside the other components to map the full pattern of which egg proteins your immune system recognizes.

Egg Allergy and Long-Term Tolerance

Many children outgrow egg allergy. In one Spanish study, children under two with diagnosed egg allergy had a roughly 66 percent cumulative probability of developing tolerance by 60 months (five years) of follow-up. Falling egg-specific IgE levels generally track with this process. Sensitization to multiple components, including Gal d 1 through Gal d 5, is associated with allergy that persists longer.

Gal d 4 has not been shown to independently predict whether allergy will resolve or persist. It contributes to the overall picture of how broadly your immune system has reacted to egg, but it does not anchor decisions on its own.

Tracking Your Trend

A single IgE reading captures one moment. Sensitization patterns shift, especially in young children who are progressing toward tolerance, and in anyone going through structured exposure or immunotherapy. Tracking how your Gal d 4 level changes over time tells you more than any one number, because the direction and pace of change are themselves clinically meaningful.

A reasonable approach: get a baseline that includes whole egg white IgE plus the Gal d 1 to 4 components and total IgE, then retest in 6 to 12 months if you are watching for resolution, or sooner if you are undergoing oral immunotherapy. Falling component IgE levels, especially Gal d 1, alongside rising IgG4, often signal that the body is moving toward tolerance. Discuss any plan to reintroduce egg with your clinician, since IgE testing supports but does not replace a supervised oral food challenge.

When Results Can Be Misleading

• Anti-IgE therapy: omalizumab and similar biologics bind circulating IgE and create complexes that the assay still detects, raising measured total IgE several-fold throughout treatment, with levels that may not return to pretreatment values for up to one year after the drug is stopped, even though the person is not becoming more allergic.
• Recent allergen exposure: sensitization patterns shift in the weeks after a reaction or after starting oral immunotherapy, so a single reading near these events may not reflect your stable baseline.
• Assay variation: different lab platforms (such as ImmunoCAP versus 3gAllergy) can give different numeric values for the same sample, so compare trends within the same lab when possible.
• Cross-reactivity: sensitization detected in blood does not always translate to clinical reactions, particularly for lower-abundance components like Gal d 4, where positive IgE can occur without symptoms.

Decision Pathway for Unexpected Results

If your Gal d 4 IgE comes back elevated but you have never had a reaction to egg, do not start avoiding eggs based on the number alone. Sensitization without symptoms is common. The right next step is to look at the full panel: whole egg white IgE, Gal d 1, 2, 3, and 5, along with total IgE. The pattern across these markers gives a more accurate read on your actual risk than any single component.

If Gal d 1 and egg white IgE are also elevated, especially in a child with eczema, atopic dermatitis, or known allergy to other foods, the case for working with an allergist strengthens. They can decide whether a skin prick test, a baked egg trial, or a supervised oral food challenge makes sense. If Gal d 4 is elevated in isolation with low whole egg white and low Gal d 1, the result is more likely incidental sensitization than clinically meaningful allergy. Either way, the oral food challenge remains the gold standard for confirming or excluding allergy when the blood test picture is unclear.